uMoove’s software can turn any device with a front-facing camera into a face- and eye-tracking device. Some of the obvious uses of the technology include, allowing user interfaces to respond to movements of the head and eyes, enabling video games to respond to gaze, and analyzing attention and level of interest. But the company is now pursuing new medical applications. Yitzi Kempinski, uMoove’s founder, says that a number of neurological diseases can be diagnosed based on eye movement. By taking advantage of this, uMoove could turn many mobile devices, laptops and even video game consoles into diagnostic devices. uMoove is an early entrant in the growing eye- and face-tracking space and investors have been eager to get in early. It recently closed a $1.5 million angel round that followed its $1.5 million seed round.